PAA 3.23% 16.0¢ pharmaust limited

Ann: Resignation of Epichem CEO, page-20

  1. 2,390 Posts.
    lightbulb Created with Sketch. 1479
    "been going on for 30 years, ie, not cutting edge.

    Genetic research has been going on for over 150 years - but it is still regarded cutting edge because scientific research into the unknown is cutting edge by definition. btw, 30 years research in a highly complex series of mechanisms that control a great array of vital funcitions in our cells and bodies is still very new.

    You made the comment because you needed to dump/hose down anything positive about this program. It fits in with your mantra of "spin" and "no progress" It fits in with your dumping on the work of ONJCRI. It fits in with your dumping on the professionalism of the third party institutions and staff running the trials when you say they're only continuing it for the money. And so on and on.

    This is why before 2020s spike you were saying that you were holding shares because you were underwater and since then, to explain why you didn't sell when PAA spiked well above 20 cents, you've been saying you've been holding because you believ the science And now, like in previous years you've forgotten that the tax rebates and grants aren't counted until the March quarter, which incidently is also the best quarter for customer reciepts. Accident? I think not. You are a professional downramper.

    Last edited by Lastly: 06/02/22
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
16.0¢
Change
0.005(3.23%)
Mkt cap ! $77.79M
Open High Low Value Volume
16.0¢ 16.0¢ 16.0¢ $95.98K 599.8K

Buyers (Bids)

No. Vol. Price($)
13 619514 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 2500 1
View Market Depth
Last trade - 11.53am 22/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.